AU2022420882A1 - An injectable pharmaceutical composition for the treatment of respiratory diseases in animals - Google Patents
An injectable pharmaceutical composition for the treatment of respiratory diseases in animals Download PDFInfo
- Publication number
- AU2022420882A1 AU2022420882A1 AU2022420882A AU2022420882A AU2022420882A1 AU 2022420882 A1 AU2022420882 A1 AU 2022420882A1 AU 2022420882 A AU2022420882 A AU 2022420882A AU 2022420882 A AU2022420882 A AU 2022420882A AU 2022420882 A1 AU2022420882 A1 AU 2022420882A1
- Authority
- AU
- Australia
- Prior art keywords
- injectable pharmaceutical
- pharmaceutical composition
- compound
- formula
- animals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21217704.2 | 2021-12-24 | ||
| EP21217704 | 2021-12-24 | ||
| PCT/EP2022/087700 WO2023118557A1 (en) | 2021-12-24 | 2022-12-23 | An injectable pharmaceutical composition for the treatment of respiratory diseases in animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2022420882A1 true AU2022420882A1 (en) | 2024-06-20 |
Family
ID=79601675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022420882A Pending AU2022420882A1 (en) | 2021-12-24 | 2022-12-23 | An injectable pharmaceutical composition for the treatment of respiratory diseases in animals |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250057790A1 (https=) |
| EP (1) | EP4452226A1 (https=) |
| JP (1) | JP2024544415A (https=) |
| CN (1) | CN118632684A (https=) |
| AR (1) | AR128074A1 (https=) |
| AU (1) | AU2022420882A1 (https=) |
| CA (1) | CA3242451A1 (https=) |
| MX (1) | MX2024007862A (https=) |
| WO (1) | WO2023118557A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4208157A1 (en) | 2020-09-04 | 2023-07-12 | Elanco Us Inc. | Palatable formulations |
| WO2025133098A2 (en) | 2023-12-21 | 2025-06-26 | Intervet International B.V. | Processes to make crystalline forms of (s)-n-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4- ((4-(((2-methoxyethyl)amino)methyl)phenyl)ethynyl)benzamide salts |
| WO2025133088A1 (en) | 2023-12-21 | 2025-06-26 | Intervet International B.V. | Crystalline forms of(s)-n-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4- ((4-(((2-methoxyethyl)amino)methyl)phenyl)ethynyl)benzamide salts |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3740421A (en) | 1966-09-19 | 1973-06-19 | Basf Wyandotte Corp | Polyoxyethylene-polyoxypropylene aqueous gels |
| BR112019012861A2 (pt) | 2016-12-23 | 2019-12-10 | Intervet Int Bv | compostos para o tratamento de doença respiratória bovina ou suína |
-
2022
- 2022-12-22 AR ARP220103558A patent/AR128074A1/es unknown
- 2022-12-23 EP EP22844124.2A patent/EP4452226A1/en active Pending
- 2022-12-23 CN CN202280085114.3A patent/CN118632684A/zh active Pending
- 2022-12-23 JP JP2024537407A patent/JP2024544415A/ja active Pending
- 2022-12-23 CA CA3242451A patent/CA3242451A1/en active Pending
- 2022-12-23 WO PCT/EP2022/087700 patent/WO2023118557A1/en not_active Ceased
- 2022-12-23 MX MX2024007862A patent/MX2024007862A/es unknown
- 2022-12-23 AU AU2022420882A patent/AU2022420882A1/en active Pending
- 2022-12-23 US US18/721,947 patent/US20250057790A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023118557A1 (en) | 2023-06-29 |
| MX2024007862A (es) | 2024-07-09 |
| CN118632684A (zh) | 2024-09-10 |
| AR128074A1 (es) | 2024-03-20 |
| JP2024544415A (ja) | 2024-11-29 |
| EP4452226A1 (en) | 2024-10-30 |
| CA3242451A1 (en) | 2023-06-29 |
| US20250057790A1 (en) | 2025-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250057790A1 (en) | An injectable pharmaceutical composition for the treatment of respiratory diseases in animals | |
| EP1626739B1 (en) | Compositions comprising florfenicol or a structurally related compound for treating infection in cattle and swine | |
| JP4772324B2 (ja) | ウシおよびブタにおける感染を処置するための組成物および方法 | |
| JP2006528705A5 (https=) | ||
| CA1273579A (en) | Bactericidal formulations for use in the area of veterinary medicine | |
| JP3470904B2 (ja) | 非経口的投与用の安定な組成物及びその使用 | |
| JPH08508032A (ja) | タイロシンを含有する長期持続性動物薬 | |
| JPS6016919A (ja) | 抗糸状菌剤 | |
| EP1875913A1 (en) | Compositions and method for treating infection in cattle and swine | |
| KR20250106485A (ko) | 동물의 피부 질환을 치료하기 위한 조성물 | |
| AU2006233264A1 (en) | Compositions and method for treating infection in cattle and swine | |
| JPH11171789A (ja) | 直腸投与用骨代謝関連ペプチドホルモン製剤 | |
| AU2013200147A1 (en) | Compositions for treating infection in cattle and swine | |
| HK1112720A (en) | Compositions and method for treating infection in cattle and swine |